Development of potent inhibitors of DNA-dependent protein kinase (DNA-PK)

被引：0

作者：

Barrett, Lauren ^{[1
]}

Rennison, Tommy ^{[1
]}

Clapham, Kate M. ^{[1
]}

Rodriguez-Aristegui, Sonsoles ^{[1
]}

Bardos, Julia ^{[2
]}

Curtin, Nicola J. ^{[1
]}

Dennis, M. ^{[3
]}

Finlay, Ray ^{[3
]}

Golding, Bernard T. ^{[1
]}

Hardcastle, Ian R. ^{[1
]}

Newell, David R. ^{[1
]}

Young, Gail ^{[3
]}

Cano, Celine ^{[1
]}

Griffin, Roger J. ^{[1
]}

机构：

[1] Newcastle Univ, Northern Inst Canc Res, Newcastle Canc Ctr, Dept Drug Discovery, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[2] KuDOS Pharmaceut Ltd, Cambridge CB4 0PE, Cambs, England

[3] AstraZeneca, Alderley Pk SK10 4TF, Cheshire, England

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 245卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

339-MEDI

引用

页数：1

共 50 条

[1] Development of potent inhibitors of the DNA-dependent protein kinase (DNA-PK)
Cano, Celine
Bailey, Chris
Bardos, Julia
Curtin, Nicola
Frigerio, Mark
Golding, Bernard
Hardcastle, Ian
Hummersone, Marc
Menear, Keith
Newell, David
Saravanan, Kappusamy
Shea, K.
Smith, Graeme
Griffin, Roger
CANCER RESEARCH, 2010, 70
[2] Development of potent inhibitors of the DNA-dependent protein kinase (DNA-PK)
Cano, Celine
Curtin, Nicola
Hardcastle, Ian
Golding, Bernard
Smith, Graeme
Newell, Herbie
Griffin, Roger
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[3] Development of potent inhibitors of DNA-dependent protein kinase (DNA-PK)
Clapham, K. M.
Rennison, T.
Rodriguez-Aristegui, S.
Bardos, J.
Curtin, N. J.
Golding, B. T.
Hardcastle, I. R.
Newell, D. R.
Cano, C.
Griffin, R. J.
EJC SUPPLEMENTS, 2010, 8 (07): : 140 - 140
[4] Development of potent water-soluble inhibitors of the DNA-dependent protein kinase (DNA-PK)
Cano, C.
Curtin, N. J.
Golding, B. T.
Haggerty, K.
Hardcastle, I. R.
Hummersone, M.
Menear, K.
Richardson, C.
Smith, G. C. M.
Griffin, R. J.
EJC SUPPLEMENTS, 2008, 6 (12): : 41 - 42
[5] Design and synthesis of novel DNA-dependent protein kinase (DNA-PK) inhibitors
Barbeau, OR
Golding, BT
Griffin, RJ
Hardcastle, IR
Smith, GCM
Richardson, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2718 - U2718
[6] Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives
Clapham, Kate M.
Rennison, Tommy
Jones, Gavin
Craven, Faye
Bardos, Julia
Golding, Bernard T.
Griffin, Roger J.
Haggerty, Karen
Hardcastle, Ian R.
Thommes, Pia
Ting, Attilla
Cano, Celine
ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (33) : 6747 - 6757
[7] 8-biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK)
Murr, Marine Desage-El
Cano, Celine
Golding, Bernard T.
Hardcastle, Ian R.
Hummersome, Marc
Frigerio, Mark
Curtin, Nicola J.
Menear, Keith
Richardson, Caroline
Smith, Graeme C. M.
Griffin, Roger J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) : 4885 - 4890
[8] DNA-BINDING BY THE THE HUMAN DNA-DEPENDENT PROTEIN-KINASE, DNA-PK
POLTORATSKY, V
MALIK, N
SAMSON, G
LIEBER, M
CARTER, T
FASEB JOURNAL, 1995, 9 (06): : A1394 - A1394
[9] Regulation of the DNA-dependent protein kinase (DNA-PK) activity in eukaryotic cells
Muller, C
Calsou, P
Frit, P
Salles, B
BIOCHIMIE, 1999, 81 (1-2) : 117 - 125
[10] The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight
LeesMiller, SP
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1996, 74 (04): : 503 - 512

← 1 2 3 4 5 →